345
Participants
Start Date
June 30, 2009
Primary Completion Date
October 31, 2012
Study Completion Date
October 31, 2012
Insulin Glargine (HOE901)/NPH Insulin
"Arm 1: Subcutaneous injection of Insulin Glargine with the TactiPen® injector pen once daily at any time, but each day at the same time~Arm 2: Subcutaneous injection of Protamine Hagedorn basal insulin with the TactiPen® injector pen once or twice daily at the discretion of the treating physician~The starting dose is 10 I.U. (NPH basal insulin) resp. 10 U (insulin glargine) per day.~The dose adjustments will be based on the results of self-monitoring."
Sanofi-Aventis Administrative Office, Berlin
Lead Sponsor
Sanofi
INDUSTRY